Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 6, 2016, Pages 875-886.e6

  Berhane, Sarah ^a   Toyoda, Hidenori ^b   Tada, Toshifumi ^b   Kumada, Takashi ^b   Kagebayashi, Chiaki ^c   Satomura, Shinji ^c   Schweitzer, Nora ^d   Vogel, Arndt ^d   Manns, Michael P ^d   Benckert, Julia ^e   Berg, Thomas ^e   Ebker, Maria ^f   Best, Jan ^g   Dechêne, Alexander ^g   Gerken, Guido ^g   Schlaak, Joerg F ^h   Weinmann, Arndt ⁱ   Wörns, Marcus A ⁱ   Galle, Peter ⁱ   Yeo, Winnie ^j   Mo, Frankie ^j   Chan, Stephen L ^j   Reeves, Helen ^k,l   Cox, Trevor ^a   Johnson, Philip ^a,m   more..

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b OGAKI MUNICIPAL HOSPITAL   (Japan)

^c Wako Life Sciences   (United States)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^f UNIVERSITY OF LEIPZIG   (Germany)

^g UNIVERSITY HOSPITAL ESSEN   (Germany)

^h Evangelisches Krankenhaus Duisburg Nord   (Germany)

ⁱ UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^j CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^k NEWCASTLE UNIVERSITY   (United Kingdom)

^l FREEMAN HOSPITAL   (United Kingdom)

^m CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

more..

Author keywords

Diagnostic; Liver Cancer; Prognostic Marker; Quantification

Indexed keywords

ALPHA FETOPROTEIN; ALPHA FETOPROTEIN L3; DECARBOXYPROTHROMBIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BALAD 2; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHRONIC LIVER DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GALAD; GERMANY; HEPATOBILIARY SYSTEM TUMOR; HONG KONG; HUMAN; JAPAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCREAS ADENOCARCINOMA; PREDICTION; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL; TUMOR VOLUME; VIRUS HEPATITIS; ASIA; BLOOD; CARCINOMA, HEPATOCELLULAR; DECISION SUPPORT SYSTEM; DIAGNOSTIC TEST; EUROPE; LIVER NEOPLASMS; MIDDLE AGED; PROCEDURES; SURVIVAL ANALYSIS; VALIDATION STUDY;

ADULT; AGED; ASIA; BIOMARKERS; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DECISION SUPPORT TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; EUROPE; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 84964689651     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.12.042     Document Type: Article

References (24)

1. Johnson P.J., Pirrie S.J., Cox T.F., et al. The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers. Cancer Epidemiol Biomarkers Prev 2014, 23:144-153.
2. Kagebayashi C., Yamaguchi I., Akinaga A., et al. Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis. Anal Biochem 2009, 388:306-311.
3. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
4. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011, 53:1020-1022.
5. Bolondi L., Sofia S., Siringo S., et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001, 48:251-259.
6. Dyson J., Jaques B., Chattopadyhay D., et al. Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team. J Hepatol 2014, 60:110-117.
7. Siegel A.B., Zhu A.X. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer 2009, 115:5651-5661.
8. Toyoda H., Kumada T., Osaki Y., et al. Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers. Clin Gastroenterol Hepatol 2006, 4:1528-1536.
9. Fox R., Berhane S., Teng M., et al. Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model. Br J Cancer 2014, 110:2090-2098.
10. Chan S.L., Mo F., Johnson P., et al. Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma. J Gastroenterol Hepatol 2015, 30:1529-1535.
11. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
12. Johnson P.J., Berhane S., Kagebayashi C., et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 2015, 33:550-558.
13. Newson R.B. Comparing the predictive powers of survival models using Harrell's C or Somers' D. Stata J 2010, 10:339.
14. Taktak AFG, Eleuteri A, Lake SP, et al. Evaluation of prognostic models: discrimination and calibration performance. In: Proceedings of the 3rd International Conference on Computational Intelligence in Medicine and Healthcare, 2007.
15. Akaike H. Information theory as an extension of the maximum likelihood principle. In Petrov BN, ed. Second international symposium on information theory. 1973.
16. Chapter 2: diagnosis and surveillance. Hepatol Res 2010, 40:16-47. The Japan Society of Hepatology.
17. Kudo M., Matsui O., Izumi N., et al. JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the Liver Cancer Study Group of Japan. Liver Cancer 2014, 3:458-468.
18. Ertle J.M., Heider D., Wichert M., et al. A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma. Digestion 2013, 87:121-131.
19. Del Priore G., Zandieh P., Lee M.-J. Treatment of continuous data as categoric variables in obstetrics and gynecology. Obstet Gynecol 1997, 89:351-354.
20. Royston P., Altman D.G., Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 2006, 25:127-141.
21. Marrero J.A., Feng Z., Wang Y., et al. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology 2009, 137:110-118.
22. Caviglia G.P., Abate M.L., Petrini E., et al. Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection. Hepatol Res 2015, 17:12544.
23. Singal A., Volk M.L., Waljee A., et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 2009, 30:37-47.
24. Ikai I., Kudo M., Arii S., et al. Report of the 18th follow-up survey of primary liver cancer in Japan. Hepatol Res 2010, 40:1043-1059.